PROTEOSTASIS THERAPEUTICS, INC. Uncategorized Contracts & Agreements
29 Contracts & Agreements
- Exclusivity and Right of First Offer Agreement, dated as of July 3, 2024, by and between Kineta, Inc. and TuHURA Biosciences, Inc (Filed With SEC on July 8, 2024)
- Open Market Sale AgreementSM, dated February 10, 2023, by and between Kineta, Inc. and Jefferies LLC (Filed With SEC on February 10, 2023)
- Second Amendment to Kineta 2010 Plan (Filed With SEC on August 29, 2022)
- First Amendment to Kineta 2010 Plan (Filed With SEC on August 29, 2022)
- Form of Lock-up Agreement, dated June 5, 2022, by each of the parties named in each agreement therein (Filed With SEC on June 6, 2022)
- Form of Kineta Support Agreement, dated June 5, 2022, by and among Yumanity, Kineta and each of the parties named in each agreement therein (Filed With SEC on June 6, 2022)
- Form of Yumanity Support Agreement, dated June 5, 2022, by and among Kineta, Yumanity and each of the parties named in each agreement therein (Filed With SEC on June 6, 2022)
- Description of Securities Registered pursuant to Section 12 of the Securities Exchange Act of 1934, as amended (Filed With SEC on March 24, 2022)
- D. Smith Offer Letter (redacted) (Filed With SEC on August 12, 2021)
- A. Verma Offer Letter (redacted) (Filed With SEC on August 12, 2021)
- Open Market Sale Agreement SM, dated April 8, 2021, by and between Yumanity Therapeutics, Inc., and Jefferies LLC (Filed With SEC on April 8, 2021)
- Description of Securities Registered pursuant to Section 12 of the Securities Exchange Act of 1934, as amended (Filed With SEC on March 31, 2021)
- Form of Support Agreement, by and between Proteostasis Therapeutics, Inc., Yumanity Therapeutics, Inc. and Yumanity Holdings, LLC (Filed With SEC on September 23, 2020)
- Form of Yumanity Lock-Up Agreement, dated August 22, 2020, by each of the parties named in each agreement therein (Filed With SEC on August 24, 2020)
- Form of PTI Lock-Up Agreement, dated August 22, 2020, by each of the parties named in each agreement therein (Filed With SEC on August 24, 2020)
- Form of Yumanity Support Agreement, dated August 22, 2020, by and between PTI, Yumanity and each of the parties named in each agreement therein (Filed With SEC on August 24, 2020)
- Form of PTI Support Agreement, dated August 22, 2020, by and between Yumanity, PTI and each of the parties named in each agreement therein (Filed With SEC on August 24, 2020)
- Form of CVR Agreement by and between PTI and the CVR Rep (Filed With SEC on August 24, 2020)
- Form of Amended and Restated Executive Agreement (Filed With SEC on March 10, 2020)
- Description of Securities Registered pursuant to Section 12 of the Securities Exchange Act of 1934, as amended (Filed With SEC on March 10, 2020)
- Offer Letter, dated August 3, 2018, by and between the Company and Sandra Zimmerman (Filed With SEC on August 8, 2018)
- ProteostasisTherapeutics, Inc. | 200 Technology Square, Fourth Floor, Cambridge, MA 02139 | T: 617 ###-###-#### (Filed With SEC on July 31, 2017)
- Proteostasis Therapeutics, Inc. | 200 Technology Square, Fourth Floor, Cambridge, MA 02139 | T: 617 ###-###-#### (Filed With SEC on November 10, 2016)
- Proteostasis Therapeutics, Inc. | 200 Technology Square, Fourth Floor, Cambridge, MA 02139 | T: 617 ###-###-#### (Filed With SEC on November 10, 2016)
- Proteostasis Therapeutics, Inc. | 200 Technology Square, Fourth Floor, Cambridge, MA 02139 | T: 617 ###-###-#### (Filed With SEC on August 8, 2016)
- Proteostasis Therapeutics, Inc. | 200 Technology Square, Fourth Floor, Cambridge, MA 02139 | ###-###-#### (Filed With SEC on March 16, 2016)
- Proteostasis Therapeutics, Inc. | 200 Technology Square, Fourth Floor, Cambridge, MA 02139 | ###-###-#### (Filed With SEC on March 16, 2016)
- THIRD AMENDED ANDRESTATED STOCKHOLDERS AGREEMENT (Filed With SEC on February 1, 2016)
- Void after 5:00p.m. New York Time on the Expiration Date (as defined below) (Filed With SEC on December 23, 2015)
